Revance Financials

Revance Stock Summary

Revance competes with DiaMedica Therapeutics, Akero Therapeutics, Nuvalent, Immunocore Holdings, and Ventyx Biosciences. Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Revance Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 495 people.

Revance Key Financial Ratios

Revance Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Revance's current stock value. Our valuation model uses many indicators to compare Revance value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revance competition to find correlations between indicators driving Revance's intrinsic value. More Info.Revance is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Revance's earnings, one of the primary drivers of an investment's value.

Revance Market Pulse

Along with financial statement analysis, the daily predictive indicators of Revance help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Revance. We use our internally-developed statistical techniques to arrive at the intrinsic value of Revance based on widely used predictive technical indicators. In general, we focus on analyzing Revance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Revance's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

If you are still planning to invest in Revance check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Revance's history and understand the potential risks before investing.